Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

DNDi and Pharco Pharmaceuticals to test ravidasvir and sofosbuvir as affordable hepatitis C regimen

April 14, 2016

Evaluating safety and pharmacokinetics in dose escalation of WCK-771 and WCK-2349

April 14, 2016

Mul-1867 shows promising activity against multidrug-resistant Pseudomonas aeruginosa

April 14, 2016

Researchers present results from in vitro and in vivo studies of WCK-4282

April 14, 2016

Riboscience divulges respiratory syncytial virus RNA replication inhibitors

April 14, 2016

FDA grants orphan drug designation for ATI-1501

April 14, 2016

FDA grants orphan drug designation to TGV-Inhalonix's Mul-1867

April 13, 2016

Phase Ia study evaluates Ebola virus vaccination with VRC-EBOADC076-00-VP followed by MVA-EBOZ

April 13, 2016

BTA-585 enters phase IIa trial for the treatment of RSV infections

April 12, 2016

Encouraging results seen in phase II murepavadin study

April 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...